'All In': a pragmatic framework for COVID-19 testing and action on a global scale.
Journal
EMBO molecular medicine
ISSN: 1757-4684
Titre abrégé: EMBO Mol Med
Pays: England
ID NLM: 101487380
Informations de publication
Date de publication:
08 06 2020
08 06 2020
Historique:
pubmed:
7
5
2020
medline:
18
6
2020
entrez:
7
5
2020
Statut:
ppublish
Résumé
Current demand for SARS-CoV-2 testing is straining material resource and labor capacity around the globe. As a result, the public health and clinical community are hindered in their ability to monitor and contain the spread of COVID-19. Despite broad consensus that more testing is needed, pragmatic guidance toward realizing this objective has been limited. This paper addresses this limitation by proposing a novel and geographically agnostic framework (the 4Ps framework) to guide multidisciplinary, scalable, resource-efficient, and achievable efforts toward enhanced testing capacity. The 4Ps (Prioritize, Propagate, Partition, and Provide) are described in terms of specific opportunities to enhance the volume, diversity, characterization, and implementation of SARS-CoV-2 testing to benefit public health. Coordinated deployment of the strategic and tactical recommendations described in this framework has the potential to rapidly expand available testing capacity, improve public health decision-making in response to the COVID-19 pandemic, and/or to be applied in future emergent disease outbreaks.
Identifiants
pubmed: 32375201
doi: 10.15252/emmm.202012634
pmc: PMC7267598
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12634Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM125498
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM118228
Pays : United States
Informations de copyright
© 2020 The Authors. Published under the terms of the CC BY 4.0 license.
Références
Bull World Health Organ. 2017 Sep 1;95(9):639-645
pubmed: 28867844
J Immunotoxicol. 2020 Dec;17(1):51-58
pubmed: 32124652
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32317257